scispace - formally typeset
T

Terumitsu Tanaka

Researcher at Takeda Pharmaceutical Company

Publications -  16
Citations -  742

Terumitsu Tanaka is an academic researcher from Takeda Pharmaceutical Company. The author has contributed to research in topics: Pericardial fluid & Myocardial infarction. The author has an hindex of 10, co-authored 16 publications receiving 715 citations. Previous affiliations of Terumitsu Tanaka include Kyoto University.

Papers
More filters
Journal ArticleDOI

Aortic Arch Reconstruction by Transluminally Placed Endovascular Branched Stent Graft

TL;DR: Careful, longer follow-up and further extensive clinical trials are awaited toward establishing this technique as a recommendable alternative to surgical treatment of thoracic aortic aneurysms.
Journal ArticleDOI

Elevated Basic Fibroblast Growth Factor in Pericardial Fluid of Patients With Unstable Angina

TL;DR: This finding provides new evidence that bFGF plays an important role in mediating collateral growth in humans.
Journal ArticleDOI

Marked Elevation of Brain Natriuretic Peptide Levels in Pericardial Fluid Is Closely Associated With Left Ventricular Dysfunction

TL;DR: BNP may be secreted from the heart into the pericardial space in response to left ventricular dysfunction, and it may have a pathophysiologic role in heart failure as an autocrine/paracrine factor.
Journal ArticleDOI

Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina

TL;DR: Sarpog Relate augments flow reserve of the collateral circulation and improves exercise capacity in anginal patients with well-developed collaterals, indicating that a serotonin blocker, sarpogrelate, is useful not only as an antiplatelet drugs, but as anAntianginal drug.